Two Sigma Advisers’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-583,428
| Closed | -$3.52M | – | 2655 |
|
|
2019
Q4 | $3.52M | Buy |
583,428
+12,000
| +2% | +$72.4K | 0.01% | 980 |
|
|
2019
Q3 | $2.06M | Buy |
571,428
+185,600
| +48% | +$668K | 0.01% | 1098 |
|
|
2019
Q2 | $1.03M | Buy |
385,828
+87,100
| +29% | +$233K | ﹤0.01% | 1498 |
|
|
2019
Q1 | $884K | Sell |
298,728
-9,100
| -3% | -$26.9K | ﹤0.01% | 1584 |
|
|
2018
Q4 | $489K | Buy |
307,828
+293,815
| +2,097% | +$467K | ﹤0.01% | 1786 |
|
|
2018
Q3 | $52K | Sell |
14,013
-20,400
| -59% | -$75.7K | ﹤0.01% | 2174 |
|
|
2018
Q2 | $97K | Buy |
+34,413
| New | +$97K | ﹤0.01% | 2275 |
|
|
2018
Q1 | – | Sell |
-108,913
| Closed | -$314K | – | 2477 |
|
|
2017
Q4 | $314K | Buy |
+108,913
| New | +$314K | ﹤0.01% | 1928 |
|
|
2017
Q1 | – | Sell |
-58,185
| Closed | -$240K | – | 2525 |
|
|
2016
Q4 | $240K | Buy |
58,185
+26,357
| +83% | +$109K | ﹤0.01% | 2124 |
|
|
2016
Q3 | $258K | Buy |
31,828
+8,200
| +35% | +$66.5K | ﹤0.01% | 1941 |
|
|
2016
Q2 | $184K | Sell |
23,628
-13,772
| -37% | -$107K | ﹤0.01% | 1881 |
|
|
2016
Q1 | $289K | Sell |
37,400
-19,600
| -34% | -$151K | ﹤0.01% | 1688 |
|
|
2015
Q4 | $615K | Buy |
+57,000
| New | +$615K | ﹤0.01% | 1255 |
|
|
2014
Q4 | – | Sell |
-94,028
| Closed | -$938K | – | 2337 |
|
|
2014
Q3 | $938K | Buy |
94,028
+21,528
| +30% | +$215K | 0.01% | 946 |
|
|
2014
Q2 | $549K | Buy |
+72,500
| New | +$549K | ﹤0.01% | 1297 |
|